Skip to main content

Blickenstaff Kim D

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Blickenstaff Kim D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

TNDM Tandem Diabetes Care Inc

Director7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 10, 2021 (view filing)Aug 6-94 daysBlickenstaff Kim DDirectorSSale−82.8K$107.70−$8.92M−20.6%319.6K after3 lots
Aug 12, 2021 (view filing)Aug 102 daysBlickenstaff Kim DDirectorSSale−3.21K$107.21−$344.1K−1.0%316.4K after
Aug 16, 2021 (view filing)Aug 12-134 daysBlickenstaff Kim DDirectorSSale−64.0K$106.83−$6.84M−20.2%252.4K after2 lots
Aug 18, 2021 (view filing)Aug 16-172 daysBlickenstaff Kim DDirectorSSale−50.0K$108.96−$5.45M−19.8%202.4K after3 lots
Sep 3, 2021 (view filing)Sep 21 dayBlickenstaff Kim DDirectorSSale−28.7K$113.36−$3.25M−12.4%202.4K after2 lots
May 19, 2022 (view filing)May 172 daysBlickenstaff Kim DDirectorSSale−10.8K$92.91−$999.9K−5.0%205.2K after
Nov 22, 2024 (view filing)Nov 20-212 daysBlickenstaff Kim DDirectorSSale−40.0K$31.04−$1.24M−19.5%165.2K after2 lots

NUVB Nuvation Bio Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 13, 2024 (view filing)Jun 112 daysBlickenstaff Kim DDirectorPPurchaseClass A Common Stock+172.2K$2.90+$499.3KNew position172.2K after